292 related articles for article (PubMed ID: 34379232)
1. Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling.
Kurakula K; Hagdorn QAJ; van der Feen DE; Vonk Noordegraaf A; Ten Dijke P; de Boer RA; Bogaard HJ; Goumans MJ; Berger RMF
Angiogenesis; 2022 Feb; 25(1):99-112. PubMed ID: 34379232
[TBL] [Abstract][Full Text] [Related]
2. Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension.
Rai N; Sydykov A; Kojonazarov B; Wilhelm J; Manaud G; Veeroju S; Ruppert C; Perros F; Ghofrani HA; Weissmann N; Seeger W; Schermuly RT; Novoyatleva T
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35058248
[TBL] [Abstract][Full Text] [Related]
3. Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling.
Kurakula K; Sun XQ; Happé C; da Silva Goncalves Bos D; Szulcek R; Schalij I; Wiesmeijer KC; Lodder K; Tu L; Guignabert C; de Vries CJM; de Man FS; Vonk Noordegraaf A; Ten Dijke P; Goumans MJ; Bogaard HJ
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31273046
[TBL] [Abstract][Full Text] [Related]
4. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
6. The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-β-signalling pathways in an SMC/EC-crosstalk-associated manner.
Bai Y; Wang J; Chen Y; Lv T; Wang X; Liu C; Xue H; He K; Sun L
Basic Res Cardiol; 2021 Sep; 116(1):53. PubMed ID: 34546460
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle cross-talk between pulmonary artery smooth muscle cells and endothelium during excessive TGF-β signalling: implications for PAH vascular remodelling.
de la Cuesta F; Passalacqua I; Rodor J; Bhushan R; Denby L; Baker AH
Cell Commun Signal; 2019 Nov; 17(1):143. PubMed ID: 31703702
[TBL] [Abstract][Full Text] [Related]
8. Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.
Zabini D; Granton E; Hu Y; Miranda MZ; Weichelt U; Breuils Bonnet S; Bonnet S; Morrell NW; Connelly KA; Provencher S; Ghanim B; Klepetko W; Olschewski A; Kapus A; Kuebler WM
Am J Respir Crit Care Med; 2018 Jan; 197(2):244-260. PubMed ID: 29095649
[TBL] [Abstract][Full Text] [Related]
9. A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.
Dickinson MG; Kowalski PS; Bartelds B; Borgdorff MA; van der Feen D; Sietsma H; Molema G; Kamps JA; Berger RM
Cardiovasc Res; 2014 Sep; 103(4):573-84. PubMed ID: 25028387
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection.
Li W; Quigley K
Biochem Soc Trans; 2024 Jun; 52(3):1515-1528. PubMed ID: 38716930
[TBL] [Abstract][Full Text] [Related]
12. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
13. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
14. Pin1 deficiency causes endothelial dysfunction and hypertension.
Chiasson VL; Munshi N; Chatterjee P; Young KJ; Mitchell BM
Hypertension; 2011 Sep; 58(3):431-8. PubMed ID: 21810655
[TBL] [Abstract][Full Text] [Related]
15. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
Upton PD; Morrell NW
Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
Ma X; Yao J; Yue Y; Du S; Qin H; Hou J; Wu Z
Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):206-211. PubMed ID: 28475806
[TBL] [Abstract][Full Text] [Related]
17. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY
Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
[TBL] [Abstract][Full Text] [Related]
19. Pathologic role of peptidyl-prolyl isomerase Pin1 in pulmonary artery remodeling.
Wu C; Ha Y; Zou Y; Liao X; Zhang S; Zhang X; Li R; Xing J; Jie W; Guo J; Li J; Shen Z
Am J Transl Res; 2021; 13(10):11162-11177. PubMed ID: 34786049
[TBL] [Abstract][Full Text] [Related]
20. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
Chen M; Shen H; Zhu L; Yang H; Ye P; Liu P; Gu Y; Chen S
J Cell Physiol; 2019 Aug; 234(10):17482-17493. PubMed ID: 30786011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
